Clinical Trial Update: A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating the combination of Sonrotoclax with Zanubrutinib versus Zanubrutinib alone in previously untreated chronic lymphocytic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Sonrotoclax
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: BeOne Medicines | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING